1. Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC) and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China
2. Chongqing Technical Innovation Center for Quality Evaluation and Identification of Authentic Medicinal Herbs, Chongqing, China
3. School of Medicine, Chongqing University, Chongqing, China
4. Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, ChinaTumor immune regulation mechanism; Synergistic mechanism of tumor epigenetics and immunity
Tumors are complex ecosystems composed of mixed populations of cells residing within dynamic microenvironmental niches. The immune system interacts intimately with tumors throughout the entire process of disease development and metastasis. This crosstalk between immune cells and cancer cells can inhibit and enhance tumor growth and is now gradually classified as the hallmark of cancer. Although many articles have been published on how tumors evade the attack of the immune system, there are still many unknown pieces of information awaiting exploration, and for researchers and clinicians, it remains a formidable task to discover effective cancer therapies based on the results of mechanistic exploration.
In this special issue, we welcome studies and reviews covering the following topics:
1. Tumorigenesis and immune responses
2. Tumor progression and immunity
3. Signal pathways that tumors exploit to avoid immune responses
4. Epigenetic mechanism of anti-tumor immune response
5. Tumor heterogeneity and immune responses
6. Immune system and cancer metastasis
7. Cancer drug resistance and immune response
8. Strategies development for cancer immunotherapy
FBXW7 in leukemia: A critical regulator of oncogenic stability and a potential therapeutic target
Emerging immunomodulatory effects of CDK4/6 inhibitors in breast cancer therapy: A comprehensive review
RIBC2 expression as a potential diagnostic and prognostic biomarker associated with tumor progression and immune modulation in breast cancer
Complementing a pair of distinct engineered oncolytic viruses with functionalized magneto-nanoparticles for enhanced cancer targeting therapy: A revisit